Last $0.0061 USD
Change Today 0.00 / 0.00%
Volume 0.0
VIAP On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 10/24/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Israel F. Charo M.D., Ph.D.

Scientific Advisor, VIA Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 56 board members in 3 different organizations across 3 different industries.

See Board Relationships
----

Background*

Dr. Israel F. Charo MD, PhD has been Senior Vice President of Research at ChemoCentryx, Inc. since September 22, 2014. Dr. Charo serves as a Scientific Advisor of VIA Pharmaceuticals, Inc. He is a Senior Investigator/Associate Director at the Gladstone Institute of Cardiovascular Disease at University of California. Dr. Charo is the Professor of Medicine at UCSF where he studies the role of chemokines in leukocyte trafficking and inflammation. His group cloned the chemokine ...

Read Full Background

Corporate Headquarters*

750 Battery Street
San Francisco, California 94111

United States

Phone: 415-283-2200
Fax: 415-283-2201

Board Members Memberships*

There is no Board Members Memberships data available.

Education*

PhD
SUNY Downstate Medical Center
MD
SUNY Downstate Medical Center

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
VIAP:US $0.01 USD 0.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Lamberto Andreotti Chief Executive Officer, Director, Member of Executive Committee and Member of Securities Issuance Committee
Bristol-Myers Squibb Company
$1.7M
George A. Scangos Ph.D.Chief Executive Officer and Director
Biogen Idec Inc.
$1.5M
Erez Vigodman Chief Executive Officer, President, Director, Member of Audit Committee and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Herve Hoppenot Chief Executive Officer, President and Director
Incyte Corporation
--
Christophe Weber President, Chief Operating Officer and Representative Director
Takeda Pharmaceutical Company Limited
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact VIA PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.